Full-Time
Private Market Analyst
Confirmed live in the last 24 hours
MicroVentures
51-200 employees
Equity crowdfunding platform for startups
Mid
Austin, TX, USA
This is a hybrid position, which implies that the candidate will need to work in the office some days.
You match the following MicroVentures's candidate preferences
Employers are more likely to interview you if you match these preferences:
- 2+ years related work experience in a finance or operations role
- Bachelor’s degree in business or related discipline
- High attention to detail
- Strong organizational skills
- Ability to work in fast-paced environment
- Self-starter
- Highly analytical
- Ability to effectively manage multiple responsibilities
- Assist with the onboarding of secondary sellers and companies to our platform
- Screen sellers/companies to determine if the investment opportunity is a good fit for the platform
- Monitor the deal flow pipeline to determine actionable next steps
- Assist with the collection, preparation, and distribution of transfer documents and other related items
- Prepare company research reports including industry and competitor analysis
- Monitor the secondary market and analyze trends
- Prepare company transfer notices and help facilitate closings weekly
- Work with operations department to set up wires to sellers
- Late stage company analysis
- Market/vertical research
- Staying current on tech industry trends
- Monitoring the venture capital and tech startup landscape
MicroVentures operates an equity crowdfunding platform that allows both accredited and non-accredited investors to invest in high-growth startups and private market opportunities. The platform simplifies the investment process by providing access to early-stage investment opportunities that were once limited to venture capitalists and institutional investors. MicroVentures generates revenue through a dual-fee structure, where investors pay a fee based on their investment amount, and companies pay a fee to list their fundraising campaigns. Additionally, the company offers educational resources to help investors understand the risks and make informed decisions about equity crowdfunding. This focus on accessibility and education sets MicroVentures apart from its competitors in the fintech market.
Company Size
51-200
Company Stage
N/A
Total Funding
$3.2M
Headquarters
Austin, Texas
Founded
2009
Simplify's Take
What believers are saying
- Growing interest in equity crowdfunding supports MicroVentures' business model.
- Increased demand for community-driven investment platforms aligns with MicroVentures' offerings.
- Biotechnology sector's growth presents opportunities for MicroVentures to support medical research.
What critics are saying
- Rising competition from new crowdfunding platforms like Anfin.
- Potential market saturation in the equity crowdfunding space.
- Regulatory scrutiny in the fintech sector could impact MicroVentures.
What makes MicroVentures unique
- MicroVentures connects both accredited and non-accredited investors with startups.
- The platform offers early-stage investment opportunities traditionally limited to venture capitalists.
- MicroVentures uses a dual-fee structure, earning from both investors and companies.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
401(k) Retirement Plan
401(k) Company Match
Company Equity
Performance Bonus
Company News
Oakland-based Mighty Buildings, which is on a quest to build homes using 3D printing, robotics and automation, has raised a $22 million extension to its Series B round of funding. The company claims to be able to 3D print structures “two times as quickly with 95% less labor hours and 10-times less waste” than conventional construction. For example, it says it can 3D print a 350-square-foot studio apartment in just 24 hours.
3D Printed Biodegradable Mesh Designed to Deliver Cancer Drugs Directly to Tumor Site With Greater Efficacy, Reduced Side Effects
ICON, in one of the largest seed rounds for Texas start-ups in 2018, announces $9M in funding.
Rochester, MN | February 10, 2023 – Pneumeric Inc., developers of the Capnospot™ - A disposable medical device that allows visual detection of carbon dioxide during treatment of a collapsed lung with needle decompression, has raised nearly $40,000 from 124 investors through its recently launched equity crowdfunding campaign. These funds build on the $1.2 million Pneumeric has
/PRNewswire/ -- Remedium Bio, Inc., a biotechnology company developing novel gene therapies, today announced that it has closed more than $2.3M in its expanded...